Eiger Biopharmaceuticals, Inc.
SEC CIK 1305253 · EIGR · last insider filing 2023-11-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Apelian David | Director · Interim CEO | filed 2017 - 2023 |
| Mayer Eldon C. III | Director · Ex VP & Chief Commerc. Officer | filed 2018 - 2023 |
| Sachdev Amit | Director | filed 2019 - 2023 |
| Dietz Thomas John | Director | filed 2016 - 2023 |
| Murray Christine | Director | filed 2019 - 2023 |
| Loh Evan | Director | filed 2017 - 2023 |
| Glenn Jeffrey S | Director | filed 2016 - 2023 |
| Sablich Kim | Director | filed 2021 - 2023 |
| Kelly-Croswell Lisa | Director | filed 2022 - 2023 |
| Cory David A | Director · President and CEO | filed 2016 - 2022 |
| Kjellson Nina S | Director | filed 2016 - 2017 |
| Engleman Edgar | Director | filed 2016 - 2017 |
| Bramlage Charles | Director | filed 2016 - 2017 |
| Alton Gregg H | Director | filed 2014 - 2015 |
| Narachi Michael | Director | filed 2014 - 2015 |
| Cooper Graham K | Director | filed 2014 - 2015 |
| Honig Peter | Director | filed 2014 - 2015 |
| Zsebo Krisztina M | Director · President & CEO | filed 2014 - 2015 |
| Yang Patrick Y | Director | filed 2014 - 2014 |
| Funder Joshua | Director | filed 2014 - 2014 |
| Foley Todd | Director | filed 2014 - 2014 |
| Kordel Johan | Director | filed 2014 - 2014 |
| Dalton Barbara | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Choong Ingrid | Chief Business Officer | filed 2023 - 2023 |
| Vollins James | General Counsel | filed 2023 - 2023 |
| Kachioff William G | CFO | filed 2023 - 2023 |
| Atkisson Erik | GC & Chief Compliance Officer | filed 2021 - 2023 |
| Ryali Sriram | Chief Financial Officer | filed 2018 - 2022 |
| Shaffer James P | Chief Business Officer | filed 2016 - 2021 |
| Patton Stephana Eilene | See Remarks | filed 2019 - 2021 |
| Quan Joanne | Chief Medical Officer | filed 2016 - 2018 |
| Welch James H | Chief Financial Officer | filed 2016 - 2018 |
| Martins Eduardo Bruno | SVP, Liver and Infectious Dise | filed 2016 - 2017 |
| Takeya Ryan K | VP, Manufacturing | filed 2014 - 2015 |
| Laba Rebecque J | VP, Finance and Administration | filed 2014 - 2015 |
| Jackson Andrew C. | See Remarks | filed 2015 - 2015 |
| Rudy Jeffrey J | VP, Clinical Operations | filed 2014 - 2015 |
| Reed Elizabeth E | VP, General Counsel | filed 2014 - 2015 |
| Cleveland Paul B | President and CFO | filed 2014 - 2015 |
| Wiklund Fredrik | VP Corp Dvlpmnt & Invs Rltns | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.